Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia A Randomized, Double-Blind, Placebo-controlled Trial

Gerard J. Criner, Frederick M. Lang, Robert L. Gottlieb, Kusum S. Mathews, Tisha S. Wang, Todd W. Rice, Deepu Madduri, Shashi Bellam, Robert Jeanfreau, Amy H. Case, Marilyn K. Glassberg, George Marshall Lyon, Kareem Ahmad, Robert Mendelson, J. Michael DiMaio, Mary Ann P. Tran, Cedric W. Spak, Jamil A. Abbasi, Steven G. Davis, Shekhar GhamandeSteven Shen, Lisa Sherman, Simon Lowry

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia A Randomized, Double-Blind, Placebo-controlled Trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases